Infertility Treatment Market was valued at USD 1.51 Billion in 2021, and it is expected to reach USD 2.82 Billion by 2029, exhibiting a CAGR of 8.06 % during the forecast period (2022-2029). The major driving factors for global infertility treatment market include declining global fertility rate, rising number of fertility conventions worldwide, technological advancements, and accelerating public-private investments, resources, grants, and increasing adoption of surrogacy by single parents and same- sex couples. The report explores the Infertility Treatment Market’s segments (Connectivity and Content, and End Users). Data has been provided by market participants, and Distribution Channel (North America, Asia Pacific, Europe, Middle East & Africa, and South America). The MMR market report provides a thorough analysis of the rapid advances that are currently taking place across all healthcare systems sectors. Facts and figures, illustrations, and presentations are used to provide key data analysis for the historical period from 2017 to 2022. The report investigates the Infertility Treatment Market’s drivers, limitations, prospects, and barriers. This MMR report includes investor recommendations based on a thorough examination of the Infertility Treatment Market’s contemporary competitive scenario. To know about the Research Methodology:-Request Free Sample Report
Infertility Treatment Market Dynamics:Over the next seven years, High cost of Infertility Treatment is restraining infertility treatment market growth. The procedure is performed by highly skilled and trained professionals with the use of sophisticated equipment, lack of professionals further hinders growth. The threat and complications associated with the infertility treatment, and unsupportive government regulations for certain infertility treatment options act as major hindrances for the growth of the infertility treatment market. Policy initiatives also determine the long- term success of the market. The research and debates indicate the need to include infertility treatment under the insurance plan. IRDAI at present is planning to include infertility treatment(IVF) in the health insurance plan. Changes like this lead to lower burdening on the couples and additional advocating strategies for the treatment in the request. Treatment costs and croaker visits can bear negatively on the individualities. But to more serve the market, education and grants are available for couples seeking treatment. The USA market is extensively supporting similar grants for couples facing infertility issues. This request space is growing with the growth of the start-ups in the fertility sphere. The penetration of the start-ups in this fertility area is accrued to the large number of women seeking therapies and guidance on adding the chances of fertility. Start-ups like Modern Fertility are concentrated on diagnostics a step further from the apps and trackers. Infertility Treatment Market Segment Analysis: MMR provides an analysis of the key trends in each sub-segment of the Blood Irradiator Device By Procedure, the medication market segment estimated for a request share of 73 in 201. The medication segment is the largest contributor due to a wide range and operation. The adding blessing of fertility services and artistic shifts has led to high demand for medicine and treatments. The mindfulness of sterility treatment has increased over time, thereby reducing the hesitancy of people to conclude for drug. The high acceptance rate is because of the enhancement in success rate and advanced ways to cure sterility. ART procedures include different procedures like artificial copulation, in- vitro fertilization IVF, surrogacy, and others. The favourable fiscal support for ART procedures in both developed and emerging countries is another factor contributing to the growth. still, the member is likely to witness interference due to the high cost of ART procedures. The surgical interventions segment is anticipated to witness gradational growth by 2029. Surgical interventions are considered as the alternate line of care after drug. This segment is likely to see an incremental growth of around$ 200 million during the forecasting period. By End-User, Fertility clinics dominate the market due to the high success rate of fertility services and IVF clinics. The number of fertility centers is expanding across the globe. These conventions enthral the largest share in the gravidity treatment request. Fertility centers offer different services, similar as IVF programs, egg donation, ICSI, IMSI, and other services. The member is projected to hold the highest share during the forecast period. This is due to the constant rise in conventions and adding connection of clinics with fertile advisers and experts. Hospitals are a significantly fast- growing member. They give traditional medical care, similar as fertility drugs, medicines, conventions, and surgeries. They also grease procedures similar as IVF and ART, which are likely to have significant demand during the cast period. Gynaecologists and urologist conventions offer high- quality women’s healthcare services, including labour care, and define drug for fertility treatment. They're primary healthcare centers performing primary fertility evaluations among end- users. Hence, this member is anticipated to grow at a steady growth during the forecasting period. The objective of the report is to present a comprehensive analysis of the global Infertility Treatment Market to the stakeholders in the devices. The past and current status of the Surgery with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the Surgery with a dedicated study of key players that include market leaders, followers, and new entrants. PORTER, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the Surgery to the decision-makers. The reports also help in understanding the Infertility Treatment Market dynamic, structure by analysing the market segments and projecting the Infertility Treatment Market size. Clear representation of competitive analysis of key players by Vehicle type, price, financial position, Surgery portfolio, growth strategies, and End-Industrial presence in the Infertility Treatment Market make the report investor’s guide.
Infertility Treatment Market Regional InsightsThe North American End-User holds an xx% share in global Holter Monitoring Systems market. Aggregate demand for sophisticated and well-organized medical devices is driving the growth of the US market. Increasing medical costs, medical needs of the aging population, and the number of cases of surgery are also some of the drivers behind market growth. The pharmaceutical market is expected to grow rapidly, but political instability is now affecting the global economy as a whole. For example, Trump's trade war with China and the turmoil in the UK's Brevity process have created market uncertainty in the Infertility Treatment market. Business fundamentals are expected to be strong and very bullish during the forecast period.
Infertility Treatment Market Scope: Inquire before buying
Infertility Treatment Market Report Coverage Details Base Year: 2021 Forecast Period: 2022-2029 Historical Data: 2017 to 2021 Market Size in 2021: US $ 1.51 Bn. Forecast Period 2022 to 2029 CAGR: 8.06% Market Size in 2029: US $ 2.82 Bn. Segments Covered: by Procedure • Assisted Reproductive Technology • In-vitro Fertilization • Intracytoplasmic Sperm Injection • Gamete Donation • Surrogacy • Artificial Insemination • Intrauterine Insemination • Drug Therapy • ART Procedure • Surgical Intervention • Fertility Surgeries • Others by Patient • Male Treatment • Female Treatment by End-User • Fertility Centers • Hospitals & Surgical Clinics • Cryobanks • Research Institutes
Infertility Treatment Market, by Region• North America • Asia-Pacific • Europe • Middle East and Africa • South America
Key Players in the Infertility Treatment Market• CCRM • Ferring Pharmaceutical • Merck & Co • Monash IVF Group • The Cooper Company • Thermo Fisher • United Healthcare Group • Surelife Pte Ltd. • Biogenics Inc. • Cook Group Incorporated • Esco Micro Pte. Ltd. • Genea Limited • Hamilton Throne Ltd. • Ihmedical A/S • Invo Bioscience • Irvine Scientific • Ivftech APS • Kitazato • Labotect GmbH • Lifeglobal Group LLC • Medgyn Products Inc. • Microtech Ivf S.R.O. • Nikon Instruments Inc. • Ri.Mos • Rinovum Women's Health Company • Rocket Medical PLC • Somatex Medical Technologies GmbH • The Baker Company Inc. • The Cooper Companies Inc. • Thermo Fisher Scientific Inc. • Vitrolife AB • Zander Scientific Inc. Frequently Asked Questions: 1] What segments are covered in the Global Infertility Treatment Market report? Ans. The segments covered in the Infertility Treatment Market report are based on Procedure Type, Patient Type and End-User. 2] Which End-User is expected to hold the highest share in the Global Infertility Treatment Market? Ans. The Asia Pacific End-User is expected to hold the highest share in the Infertility Treatment Market. 3] What is the market size of the Global Infertility Treatment Market by 2029? Ans. The market size of the Infertility Treatment Market by 2029 is expected to reach USD 2.82 Bn. 4] What is the forecast period for the Global Infertility Treatment Market? Ans. The forecast period for the Infertility Treatment Market is 2022-2029. 5] What was the market size of the Global Infertility Treatment Market in 2021? Ans. The market size of the Infertility Treatment Market in 2021 was valued at USD 1.51 Bn.
1. Global Infertility Treatment Market: Research Methodology 2. Global Infertility Treatment Market: Executive Summary 2.1. Market Overview and Definitions 2.1.1. Introduction to Global Infertility Treatment Market 2.2. Summary 2.2.1. Key Findings 2.2.2. Recommendations for Investors 2.2.3. Recommendations for Market Leaders 2.2.4. Recommendations for New Market Entry 3. Global Infertility Treatment Market: Competitive Analysis 3.1. MMR Competition Matrix 3.1.1. Market Structure by region 3.1.2. Competitive Benchmarking of Key Players 3.2. Consolidation in the Market 3.2.1 M&A by region 3.3. Key Developments by Companies 3.4. Market Drivers 3.5. Market Restraints 3.6. Market Opportunities 3.7. Market Challenges 3.8. Market Dynamics 3.9. PORTERS Five Forces Analysis 3.10. PESTLE 3.11. Regulatory Landscape by region ● North America ● Europe ● Asia Pacific ● The Middle East and Africa ● South America 3.12. COVID-19 Impact 4. Global Infertility Treatment Market Segmentation 4.1. Global Infertility Treatment Market, By Procedure (2021-2029) ● Assisted Reproductive Technology ● In-vitro Fertilization ● Intracytoplasmic Sperm Injection ● Gamete Donation ● Surrogacy ● Artificial Insemination ● Intrauterine Insemination ● Drug Therapy ● ART Procedure ● Surgical Intervention ● Fertility Surgeries ● Others 4.2. Others Global Infertility Treatment Market, By Patient (2021-2029) ● Male Treatment ● Female Treatment 4.3. Global Infertility Treatment Market, End-User (2021-2029) ● Fertility Centers ● Hospitals & Surgical Clinics ● Cryobanks ● Research Institutes 5. North America Infertility Treatment Market (2021-2029) 5.1. North America Infertility Treatment Market, By Procedure (2021-2029) ● Assisted Reproductive Technology ● In-vitro Fertilization ● Intracytoplasmic Sperm Injection ● Gamete Donation ● Surrogacy ● Artificial Insemination ● Intrauterine Insemination ● Drug Therapy ● ART Procedure ● Surgical Intervention ● Fertility Surgeries ● Others 5.2. North America Infertility Treatment Market, By Patient (2021-2029) ● Male Treatment ● Female Treatment 5.3. North America Infertility Treatment Market, End-User (2021-2029) ● Fertility Centers ● Hospitals & Surgical Clinics ● Cryobanks ● Research Institutes 5.4. North America Infertility Treatment Market, by Country (2021-2029) ● United States ● Canada ● Mexico 6. European Infertility Treatment Market (2021-2029) 6.1. European Infertility Treatment Market, By Procedure (2021-2029) 6.2. European Infertility Treatment Market, By Patient (2021-2029) 6.3. European Infertility Treatment Market, End-User (2021-2029) 6.4. European Infertility Treatment Market, by Country (2021-2029) ● UK ● France ● Germany ● Italy ● Spain ● Sweden ● Austria ● Rest of Europe 7. Asia Pacific Infertility Treatment Market (2021-2029) 7.1. Asia Pacific Infertility Treatment Market, By Procedure (2021-2029) 7.2. Asia Pacific Infertility Treatment Market, By Patient (2021-2029) 7.3. Asia Pacific Infertility Treatment Market, End-User (2021-2029) 7.4. Asia Pacific Infertility Treatment Market, by Country (2021-2029) ● China ● India ● Japan ● South Korea ● Australia ● ASEAN ● Rest of APAC 8. Middle East and Africa Infertility Treatment Market (2021-2029) 8.1. Middle East and Africa Infertility Treatment Market, By Procedure (2021-2029) 8.2. Middle East and Africa Infertility Treatment Market, By Patient (2021-2029) 8.3. Middle East and Africa Infertility Treatment Market, End-User (2021-2029) 8.4. Middle East and Africa Infertility Treatment Market, by Country (2021-2029) ● South Africa ● GCC ● Egypt ● Nigeria ● Rest of ME&A 9. South America Infertility Treatment Market (2021-2029) 9.1. South America Infertility Treatment Market, By Procedure (2021-2029) 9.2. South America Infertility Treatment Market, By Patient (2021-2029) 9.3. South America Infertility Treatment Market, End-User (2021-2029) 9.4. South America Infertility Treatment Market, by Country (2021-2029) ● Brazil ● Argentina ● Rest of South America 10. Company Profile: Key players 10.1. Monash IVF Group 10.1.1. Company Overview 10.1.2. Financial Overview 10.1.3. Global Presence 10.1.4. Capacity Portfolio 10.1.5. Business Strategy 10.1.6. Recent Developments 10.2. CCRM 10.3. Ferring Pharmaceutical 10.4. Merck & Co 10.5. The Cooper Company 10.6. Thermo Fisher 10.7. United Healthcare Group 10.8. Surelife Pte Ltd. 10.9. Biogenics Inc. 10.10. Cook Group Incorporated 10.11. Esco Micro Pte. Ltd. 10.12. Genea Limited 10.13. Hamilton Throne Ltd. 10.14. Ihmedical A/S 10.15. Invo Bioscience 10.16. Irvine Scientific 10.17. Ivftech APS 10.18. Kitazato 10.19. Labotect GmbH 10.20. Lifeglobal Group LLC 10.21. Medgyn Products Inc. 10.22. Microtech Ivf S.R.O. 10.23. Nikon Instruments Inc. 10.24. Ri.Mos 10.25. Rinovum Women's Health Company 10.26. Rocket Medical PLC 10.27. Somatex Medical Technologies GmbH 10.28. The Baker Company Inc. 10.29. The Cooper Companies Inc. 10.30. Thermo Fisher Scientific Inc. 10.31. Vitrolife AB 10.32. Zander Scientific Inc.